SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES

par T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov
Publié 2019

SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT

par T. S. Nepomnyashchikh, D. V. Antonets, R. A. Maksyutov
Publié 2017

Obtainingvaccinia virus with increased production of extracellular enveloped virions and directing GM-CSF synthesis as a promising basis for development of antitumor drug

par T. V. Bauer, T. V. Tregubchak, S. N. Shchelkunov, R. A. Maksyutov, E. V. Gavrilova
Publié 2020

ИССЛЕДОВАНИЕ ЭФФЕКТИВНОСТИ ИНДУКЦИИ ЦИТОТОКСИЧЕСКОГО ИММУННОГО ОТВЕТА МОНОНУКЛЕАРНЫМИ КЛЕТКАМИ С ПОМОЩЬЮ ДЕНДРИТНЫХ КЛЕТОК, ТРАНСФЕЦИРОВАННЫХ ПОЛИЭПИТОПНЫМИ КОНСТРУКЦИЯМИ HER2/ERBB...

par A. Z. Maksyutov, Yu. A. Lopatnikova, V. V. Kurilin, Yu. A. Shevchenko, Yu. N. Khantakova, E. V. Gavrilova, R. A. Maksyutov, A. G. Peregudov, S. A. Zaytsev, V. A. Kozlov, S. V. Sennikov
Publié 2014

Top–down assessment of the Asian carbon budget since the mid 1990s

par R. L. Thompson, P. K. Patra, F. Chevallier, S. Maksyutov, R. M. Law, T. Ziehn, I. T. van der Laan-Luijkx, W. Peters, A. Ganshin, R. Zhuravlev, T. Maki, T. Nakamura, T. Shirai, M. Ishizawa, T. Saeki, T. Machida, B. Poulter, J. G. Canadell, P. Ciais
Publié 2016

A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers age...

par A. B. Ryzhikov, Е. А. Ryzhikov, M. P. Bogryantseva, S. V. Usova, E. D. Danilenko, E. A. Nechaeva, O. V. Pyankov, O. G. Pyankova, A. S. Gudymo, S. A. Bodnev, G. S. Onkhonova, E. S. Sleptsova, V. I. Kuzubov, N. N. Ryndyuk, Z. I. Ginko, V. N. Petrov, A. A. Moiseeva, P. Yu. Torzhkova, S. A. Pyankov, T. V. Tregubchak, D. V. Antonec, E. V. Gavrilova, R. A. Maksyutov
Publié 2021